The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data-Reference-Cited by-同舟云学术

The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data

Published:2017-11-15 Issue:2 Volume:121 Page:169-172
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Perera Marlon¹²^ORCID,Papa Nathan¹,Christidis Daniel¹^ORCID,McGrath Shannon¹,Manning Todd¹^ORCID,Roberts Matthew²,Bolton Damien¹,Lawrentschuk Nathan¹³⁴^ORCID,Sengupta Shomik¹^ORCID

Affiliation:

1. Department of Surgery; Austin Health; University of Melbourne; Heidelberg Vic. Australia

2. Faculty of Medicine; University of Queensland; Brisbane Qld Australia

3. Olivia Newton-John Cancer and Wellness Centre; Austin Health; Heidelberg Vic. Australia

4. Division of Cancer Surgery; Peter MacCallum Cancer Centre; Melbourne Vic. Australia

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14065/fullpdf

Reference6 articles.

1. US Food & Drug administration Inspections, Compliance, Enforcement, and Criminal Investigations - Sanofi Pasteur 7/12/12 Warning Letter https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm312929.htm

2. High-risk non-muscle-invasive bladder cancer - therapy options during intravesical BCG shortage;Veeratterapillay;Curr Urol Rep,2016

3. Australian Government, Department of Human Services Pharmaceutical Benefits Schedule Item Reports 2016 http://medicarestatistics.humanservices.gov.au/statistics/pbs_item.jsp

4. Testing for a unit root in time series regression;Phillips;Biometrika,1988

5. European Association of Urology Statement concerning the shortage of BCG immunotherapy by the EAU Guidelines Panel on Non-muscle invasive bladder cancer 2012 https://uroweb.org/wp-content/uploads/BCG-Press-release-NMIBC-Panel-final-Aug-13th-2012.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Role of Preoperative Neutrophil-To-Lymphocyte Ratio (NLR) and Recurrence at First Evaluation after Bacillus Calmette–Guérin (BCG) Induction in Non-Muscle-Invasive Bladder Cancer;Diagnostics;2023-10-02

2. Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer;JAMA Network Open;2023-02-28

3. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models;Bladder Cancer;2022-12-14

4. A prospective descriptive 1‐year study in France of all BCG therapy dispensations for non‐muscle‐invasive bladder cancer;BJU International;2022-12-14

5. Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage;World Journal of Urology;2022-01-27